(thirdQuint)Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina Faso.

 This study is a phase 1, randomized, double-blind, placebo-controlled, dose escalation trial of Sanaria's irradiated sporozoite vaccine (PfSPZ vaccine).

 The primary objective of this protocol is to determine the safety and reactogenicity of the PfSPZ Vaccine in malaria-experienced healthy adults.

 The secondary protocol objective is to evaluate vaccine-induced immune responses, including but not limited to, anti-CSP antibody and T cell responses against whole P.

 falciparum sporozoites and a variety of P.

 falciparum antigens from different life cycle stages.

 The study duration shall be 34 months and subject participation duration shall be 15-26 months.

.

 Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina Faso@highlight

This study is a phase 1, randomized, double-blind, placebo-controlled, dose escalation trial of Sanaria's irradiated sporozoite vaccine (PfSPZ vaccine).

 The primary objective of this protocol is to determine the safety and reactogenicity of the PfSPZ Vaccine in malaria-experienced healthy adults.

 The study duration shall be 34 months and subject participation duration shall be 15-26 months.

